[Duration of antivitamin K treatment in venous thromboembolic disease].
Pinede
L
L
Ninet
J
J
D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D013923:Thromboembolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D014812:Vitamin K